Study BME in Thailand 2007

วันพุธที่ 10 มิถุนายน พ.ศ. 2552

CLOSING REMARKS

Nanotechnology and Biomedicine(8)
Source: Neelina H. Malsch_Biomedical Nanotechnology

Nanoscale and biosystem research areas are merging with information technol- ogy and cognitive science, leading to completely new science and technology plat- forms in genome pharmaceuticals, biosystem-on-a-chip devices, regenerative medicine, neuroscience, and food systems. A key challenge is bringing together biologists and doctors with scientists and engineers interested in the new measure- ment and fabrication capabilities of nanotechnology. Another key challenge is fore- casting and addressing possible unexpected consequences of the revolutionary sys- tems and engineering developments utilized in nanobiosystems. Priority science and technology goals may be envisioned for iternational collaboration in nanoscale research and education, better comprehension of nature, increasing productivity, sustainable development, and addressing humanity and civilization issues.The confluence of biology, medicine, and nanotechnology is reflected in gov- ernment funding programs and science policies. For example, the U.S. NNI plans to increase its contributions to programs dedicated to nanobiosystems beyond the current level of about 15%; similar trends in other countries intended to better recognize nanobiosystems research have also been noted.Nanoscale assemblies of organic and inorganic matter lead to the formation of cells and other activities of the most complex known systems — the human brain and body. Nanotechnology plays a key role in understanding these processes and the advancement of biological sciences, biotechnology, and medicine. Four chapters in this volume present key issues of molecular medicine, from drug delivery and biocompatible replacement body parts to devices and systems for high throughput diagnostics and biodefense. Three other chapters provide overviews on relevant research and development programs, the social and economic contexts, and potential uncertainties surrounding nanobiomedical developments. This broad perspective is of interest not only to the scientific and medical community, but also to science policy makers, social scientists, economists, and the public.

ไม่มีความคิดเห็น:

แสดงความคิดเห็น